Eli Lilly and Company News - February 6, 2026
🟢 LLY is trading 3.6% up today as FDA pledges action against illegal copycat weight-loss drugs
LLY is trading at $1,057.59 (+3.6%) as the FDA pledges swift action against illegal copycat weight-loss drugs, reversing yesterday's sharp 8% decline. • The...
Eli Lilly Debuts Biotech Collaboration Model to Fuel Post-GLP-1 Growth in Gene Editing and Immunology
Eli Lilly and Company launched a new biotech collaboration model to accelerate early-stage drug discovery through external partnerships. This strategic...
🟢 LLY is trading 4% up today on strong Q4 earnings and upbeat 2026 guidance
LLY is trading at $1061.76 (+4.01%) in pre-market, rebounding sharply from yesterday's drop following the release of its Q4 2025 financial results. • Revenue...